Business Context and Reporting Period
This Form 8-K, dated August 4, 2026, reports on International Flavors & Fragrances Inc. (IFF). The filing focuses on a strategic divestiture announced on May 29, 2026, involving the sale of the Company's Food Ingredients business to funds advised by CVC Capital Partners. The transaction is expected to close by the end of the second quarter of 2027.
Key Financial Metrics and Transaction Details
- Transaction Structure: IFF will sell substantially all assets of the Food Ingredients disposal group while retaining an approximately 10% minority equity interest.
- Discontinued Operations: The Food Ingredients disposal group, combined with the previously completed sale of the Soy Crush, Concentrates, and Lecithin (SCL) business (closed March 2, 2026), meets the criteria for discontinued operations. Results for these groups are reclassified accordingly in recast financial information provided in Exhibit 99.1.
- Financial Data: This specific filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. It references recast unaudited financial information for periods ending March 31, 2025, through March 31, 2026, contained in Exhibit 99.1.
Material Changes
The primary material change is the reclassification of the Food Ingredients and SCL disposal groups as discontinued operations. This strategic shift is expected to have a major effect on IFF's operations and financial results. The filing clarifies that previously filed financial statements are not restated, but recast information is provided to assist investors in understanding the impact of the separation.
Guidance, Outlook, and Risks
Outlook and Management Commentary: Management anticipates the transaction will allow for continued collaboration with the Food Ingredients business and enable shareholders to participate in future value creation. The filing includes forward-looking statements regarding sales, adjusted operating EBITDA, and cash flow, subject to customary closing conditions including regulatory approvals.
Risks and Contingencies: The filing lists significant risks including demand trends, execution of strategic transactions, working capital management, legal disputes, geopolitical developments, supply chain disruptions, input cost volatility, and regulatory compliance. The Company explicitly states it does not undertake to update forward-looking statements as new information becomes available.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific recast unaudited financial figures reflecting the discontinued operations classification.
- Verify the status of regulatory approvals required for the Food Ingredients sale to close by Q2 2027.
- Confirm the valuation and terms of the retained 10% minority equity interest in the Food Ingredients business.
- Assess the impact of the SCL and Food Ingredients disposals on the Company's remaining portfolio and future growth strategy.
- Monitor for any updates to the forward-looking statements regarding sales and adjusted operating EBITDA as outlined in the cautionary statement.